How the SBIR development centre funds cancer initiatives
How the SBIR development centre funds cancer initiatives
Supporting technological initiatives in low and middle income countries
The Integrative Cancer Epidemiology Programme
Editor's Choice for February 2018
6-factor prognostic model for patients with advanced urothelial carcinoma
Comment: Urothelial cancer research from ASCO GU 2018
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer
Management of inflammatory breast cancer
Recommendation guidelines in breast cancer resolution for the Eastern Mediterranean
Expert insight: Managing neutropenia in breast cancer patients
Aspirin: 120 years of innovation, 2017 Scientific Conference, Berlin